To Amend The Prescription Drug Monitoring Program Advisory Committee; And To Amend The Confidentiality Of And The Providing Of Information By The Prescription Drug Monitoring Program.
Limits amount paid by covered persons for purchase of insulin drugs and epinephrine; requires Division of Consumer Affairs to investigate insulin prices.
Limits amount paid by covered persons for purchase of insulin drugs and epinephrine; requires Division of Consumer Affairs to investigate insulin prices.